Therapeutic efficacy of ozone in patients with diabetic foot

被引:176
作者
Martínez-Sánchez, G
Al-Dalain, SM
Menéndez, S
Re, L
Giuliani, A
Candelario-Jalil, E
Alvarez, H
Fernández-Montequín, JI
León, OS
机构
[1] Univ Havana, IFAL, CEIEB, Havana 10400, Cuba
[2] Univ Ancona, Lab Pharmacol Biotechnol, I-60131 Ancona, Italy
[3] Univ Milan, Dept Chem & Med Biochem, I-20133 Milan, Italy
关键词
ozone; diabetes (and its complications); diabetic foot; oxidative stress; antioxidant defense system;
D O I
10.1016/j.ejphar.2005.08.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxidative stress is suggested to have an important role in the development of complications in diabetes. Because ozone therapy can activate the antioxidant system, influencing the level of glycemia and some markers of endothelial cell damage, the aim of this study was to investigate the therapeutic efficacy of ozone in the treatment of patients with type 2 diabetes and diabetic feet and to compare ozone with antibiotic therapy. A randomized controlled clinical trial was performed with 101 patients divided into two groups: one (n=52) treated with ozone (local and rectal insufflation of the gas) and the other (n=49) treated with topical and systemic antibiotics. The efficacy of the treatments was evaluated by comparing the glycemic index, the area and perimeter of the lesions and biochemical markers of oxidative stress and endothelial damage in both groups after 20 days of treatment. Ozone treatment improved glycemic control, prevented oxidative stress, normalized levels of organic peroxides, and activated superoxide dismutase. The pharmacodynamic effect of ozone in the treatment of patients with neuroinfectious diabetic foot can be ascribed to the possibility of it being a superoxide scavenger. Superoxide is considered a link between the four metabolic routes associated with diabetes pathology and its complications. Furthermore, the healing of the lesions improved, resulting in fewer amputations than in control group. There were no side effects. These results show that medical ozone treatment could be an alternative therapy in the treatment of diabetes and its complications. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 161
页数:11
相关论文
共 57 条
[1]   Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus [J].
Akkus, I ;
Kalak, S ;
Vural, H ;
Caglayan, O ;
Menekse, E ;
Can, G ;
Durmus, B .
CLINICA CHIMICA ACTA, 1996, 244 (02) :221-227
[2]  
Al-Dalain SM, 2001, PHARMACOL RES, V44, P391
[3]   Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress [J].
Atalay, M ;
Laaksonen, DE ;
Niskanen, L ;
Uusitupa, M ;
Hanninen, O ;
Sen, CK .
ACTA PHYSIOLOGICA SCANDINAVICA, 1997, 161 (02) :195-201
[4]   Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia [J].
Barber, E ;
Menéndez, S ;
León, OS ;
Barber, MO ;
Merino, N ;
Calunga, JL ;
Cruz, E ;
Bocci, V .
MEDIATORS OF INFLAMMATION, 1999, 8 (01) :37-41
[5]   Advanced glycation end product-induced activation of NF-kappa B is suppressed by alpha-lipoic acid in cultured endothelial cells [J].
Bierhaus, A ;
Chevion, S ;
Chevion, M ;
Hofmann, M ;
Quehenberger, P ;
Illmer, T ;
Luther, T ;
Berentshtein, E ;
Tritschler, H ;
Muller, M ;
Wahl, P ;
Ziegler, R ;
Nawroth, PP .
DIABETES, 1997, 46 (09) :1481-1490
[6]  
Björk S, 2001, DIABETES RES CLIN PR, V54, pS13
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   THE RELATIONSHIP OF VASCULAR CHANGES TO METABOLIC FACTORS IN DIABETES-MELLITUS AND THEIR ROLE IN THE DEVELOPMENT OF PERIPHERAL-NERVE COMPLICATIONS [J].
CAMERON, NE ;
COTTER, MA .
DIABETES-METABOLISM REVIEWS, 1994, 10 (03) :189-224
[9]   Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats [J].
Candelario-Jalil, E ;
Mohammed-Al-Dalain, S ;
Fernández, OSL ;
Menéndez, S ;
Pérez-Davison, G ;
Merino, N ;
Sam, S ;
Ajamieh, HH .
JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 (04) :297-301
[10]  
CARDILE V, 1995, CELL BIOL TOXICOL, V11, P11